$275M Revs; est. $257M
$83M AEBITDA; est. $76.1M
$133M GP; est. $127M
$61M Operating CF
48.4% GM; est. 49.5%
$0.05 EPS; est. $.01
Share repurchases of $25 million during the quarter, over 1% of shares outstanding.
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.